ARTICLE | Clinical News
ReNeuron Ltd. preclinical data
February 13, 2006 8:00 AM UTC
In a rodent model of stroke, ReN001 led to a dose-dependent reversal of both sensory and motor symptoms associated with stroke disability. Previous data showed that the stem cell line derived from REN...